NSEAcquisition1d ago · 17 Sept 2026, 05:27 pm

Acquisition

Sandur Manganese & Iron Ores Limited · SANDUMA

✦ AI SummaryExpansion

Sandur Manganese & Iron Ores Limited has informed the Exchange about approval for incorporation of Wholly Owned Subsidiary, Royal Sandur MedTech Private Limited, for medical devices and consumables manufacturing.

Analysis Scores

Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sandur Manganese & Iron Ores Limited has informed the Exchange about approval for incorporation of Wholly Owned Subsidiary

Attachments (1)

📄

SANDUR_17092026172357_Ltr2SEsToBeIncorpWOS.pdf

pdf

Download →
View document text
(An ISO 9001:2015; ISO 14001:2015 and ISO 45001:2018 certified company) CIN: L85110KA1954PLC000759; Website: www.sandurgroup.com Email ID: secretarial@sandurgroup.com REGISTERED OFFICE CORPORATE OFFICE ‘SATYALAYA’, No.266 ‘SANDUR HOUSE’, No.9 Ward No.1, Palace Road Bellary Road, Sadashivanagar Sandur – 583 119, Ballari District Bengaluru – 560 080 Karnataka, India Karnataka, India Tel: 08395 260300 Tel: 080 4152 0176 - 79 / 4547 3000 SMIORE / SEC / 2026-27 / 47 17 September 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 504918 Symbol: SANDUMA Symbol: SANDUMA Dear Sir/ Madam, Sub: Approval for incorporation of Wholly Owned Subsidiary Ref: Letter No. SMIORE / SEC / 2026-27 / 19 dated 9 July 2026 pertaining to venturing into new lines of business of the Company Pursuant to Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) “SEBI (LODR)” Regulations, 2015, this is to inform Stock Exchanges that the Board of Directors of the Company at its 387th meeting held today i.e., 17 September 2026 which commenced at 4:30 P.M. and concluded at 5:00 P.M., has approved the incorporation of a Wholly Owned Subsidiary under the name and style of ‘Royal Sandur MedTech Private Limited’, subject to necessary approvals. Detailed information as required under SEBI (LODR) Regulations, 2015 read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026 in respect of the same is given in ‘Annexure A’ to this letter. Stock Exchanges are requested to kindly take the same on record. Thank you for The Sandur Manganese & Iron Ores Limited Neha Thomas Company Secretary & Compliance Officer ICSI Membership No. A60853 Encl: A/a MINES OFFICE: Deogiri - 583112, Sandur Taluk, Ballari District; Tel: +91 8395 271028 PLANT OFFICE: Metal & Ferroalloy Plant, Vyasankere, Mariyammanahalli – 583 222, Hosapete Taluk, Vijayanagara District; Tel: +91 8394 294802 / 805 Page 1 of 2 The Sandur Manganese & Iron Ores Limited Annexure A [Details as required under SEBI (LODR) Regulations, 2015 read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026] Name of the entity, date & country of Name: Royal Sandur MedTech Private Limited incorporation, etc. Date: The Company is yet to be incorporated Country of Incorporation: India Name of holding company of the to Holding Company: The Sandur Manganese & Iron Ores be incorporated company and Limited relation with the listed entity Relation: Wholly Owned Subsidiary of The Sandur Manganese & Iron Ores Limited Industry to which the entity being Medical devices and consumables manufacturing incorporated belongs Brief background about the entity Royal Sandur MedTech Private Limited will be incorporated in terms of products/ incorporated to carry on the business of medical devices line of business and consumables manufacturing including but not limited to manufacturing, processing, assembling, marketing and distribution of medical devices, surgical products, diagnostic products and healthcare consumables. Brief details of any governmental or Royal Sandur MedTech Private Limited will be regulatory approvals required for incorporated subject to applicable laws and regulatory the incorporation approvals, as required. Nature of consideration - whether Subscription of equity shares in cash cash consideration or share swap and details of the same Cost of subscription/ price at which 10,00,000 equity shares of ₹10/- each aggregating to the shares are subscribed ₹1,00,00,000/- Percentage of shareholding/ control 100% by the listed entity and/ or number of shares allotted Page 2 of 2
Sandur Manganese & Iron Ores Limited — Acquisition | BazaarWatch